44 Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.67M Buy
19,117
+2,546
+15% +$593K 1.63% 5
2025
Q4
$3.43M Sell
16,571
-831
-5% -$164K 1.15% 12
2025
Q3
$3.23M Sell
17,402
-221
-1% -$37.9K 1.1% 14
2025
Q2
$2.69M Sell
17,623
-646
-4% -$99.3K 0.95% 25
2025
Q1
$3.03M Buy
18,269
+260
+1% +$40.7K 1.14% 17
2024
Q4
$2.6M Sell
18,009
-506
-3% -$78.4K 1% 25
2024
Q3
$3.07M Buy
+18,515
New +$2.95M 1.08% 19
2023
Q2
$3.7M Buy
22,329
+10,860
+95% +$1.75M 1.26% 22
2023
Q1
$1.78M Buy
11,469
+244
+2% +$39.4K 0.6% 45
2022
Q4
$1.98M Buy
11,225
+769
+7% +$133K 0.69% 40
2022
Q3
$1.71M Buy
10,456
+866
+9% +$147K 0.7% 40
2022
Q2
$1.7M Buy
9,590
+244
+3% +$43.5K 0.66% 41
2022
Q1
$1.66M Sell
9,346
-4,855
-34% -$826K 0.6% 44
2021
Q4
$2.43M Buy
14,201
+459
+3% +$75.1K 0.84% 29
2021
Q3
$2.22M Buy
13,742
+1,035
+8% +$177K 0.85% 30
2021
Q2
$2.09M Buy
12,707
+2,756
+28% +$456K 0.81% 31
2021
Q1
$1.64M Buy
9,951
+2,737
+38% +$443K 0.68% 42
2020
Q4
$1.14M Buy
+7,214
New +$1.06M 0.52% 45

Other funds holding JNJ

44 Wealth Management's JNJ Position: Q1 2026 in Review

44 Wealth Management increased its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, buying an estimated $593K and bringing the position to 19,117 shares worth $4.67M. The position accounts for 1.63% of the portfolio, ranked #5.

44 Wealth Management first reported a position in JNJ in Q4 2020 and has held it in 18 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • 44 Wealth Management held 19,117 shares of Johnson & Johnson worth $4.67M as of Q1 2026.
  • 44 Wealth Management bought 2,546 Johnson & Johnson shares in Q1 2026, an estimated $593K.
  • Johnson & Johnson made up 1.63% of 44 Wealth Management's portfolio in Q1 2026, its #5 holding.
  • 44 Wealth Management first reported a position in Johnson & Johnson in Q4 2020 and has held it in 18 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.